The National Alliance of State & Territorial AIDS Directors (NASTAD) was awarded a $6,166,318 Cooperative Agreement under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) from the U.S. Centers for Disease Control and Prevention (CDC). This five-year award, beginning on September 30, 2024 and running through March 31, 2029, supports NASTAD in providing technical assistance, training, and capacity building services to healthcare organizations,...
This $2,000,000 Project Grant award from the Health Resources and Services Administration (HRSA) under the HIV Emergency Relief Project Grants program (CFDA 93.914) will support the Georgetown University Center for Global Health Practice and Impact, in partnership with Boston University School of Public Health, Abt Global, and consultants from the Mayo Clinic, to provide technical assistance and capacity building to HRSA 25-063 recipients. The project aims to enhance technical capacity, assist...
This $2,400,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421) is aimed at building capacity within governmental, non-governmental, tribal, and academic organizations to deliver essential public health services. The primary awardee, the National Alliance of State & Territorial AIDS Directors...
This $623,243 federal Project Grant award, titled "ACCELERATING PUBLIC HEALTH IMPACT THROUGH THE UNIVERSITY OF WASHINGTON/NASTAD RESEARCH ALLIANCE IN IMPLEMENTATION SCIENCE TO END HIV (RAISE) REGIONAL CONSULTATIVE HUB", was awarded on May 13, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The primary objective of this grant is to enhance the impact of Ending the HIV Epidemic (EHE)...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $92,699,782 Cooperative Agreement under the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939) to the City of New York Department of Health and Mental Hygiene (Health Dept). The purpose of the award is to build on the Health Dept's existing comprehensive and integrated HIV surveillance and prevention program to achieve the national Ending the HIV Epidemic (EHE)...
This Project Grant award, totaling $5,600,000, was provided by the Health Resources and Services Administration (HRSA) through the Special Projects of National Significance (SPNS) program (CFDA 93.928). The grant aims to increase access to care for people with HIV by promoting efficiencies in Ryan White HIV/AIDS Program (RWHAP) eligibility and confirmation across all RWHAP parts. The key products and services to be delivered under this award include: 1) designing and conducting a systems...
This $2,400,000 HIV Emergency Relief Project Grant (CFDA 93.914) awarded by the Health Resources and Services Administration (HRSA) will fund the "Cultivate" leadership development program led by AIDS United. The program aims to build, promote, and elevate the leadership of people with HIV in HIV care systems over a 4-year period from September 2024 to August 2028. Through this grant, AIDS United will recruit and train 200 diverse people with HIV to become leaders and trainers, who...
This $30,554,330 Cooperative Agreement award from the Department of Health and Human Services Centers for Disease Control and Prevention (CFDA 93.940 - HIV Prevention Activities Health Department Based) will support a comprehensive HIV prevention and surveillance program delivered by Health Research, Inc.'s Aids Institute Division in New York. The program aims to increase knowledge of HIV status, reduce HIV transmission, prevent new infections, improve linkage to care and viral suppression,...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $39,262,250 Cooperative Agreement to the City of Houston Department of Health and Human Services (HHD) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The funding supports enhanced HIV surveillance, testing, linkage to care, and prevention activities in Houston, Texas to help achieve the goals of the Ending the HIV Epidemic (EHE) initiative. Specifically, the HHD will: (1) expand...
This federal Cooperative Agreement award for $2,745,600.00, with a performance period from September 30, 2024 to September 29, 2029, is provided by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The award, titled "MODELING HIV, VIRAL HEPATITIS, STI, AND TB TO IMPROVE PUBLIC HEALTH - CAMP 3.0: THE COALITION FOR APPLIED MODELING FOR PREVENTION," supports comprehensive efforts to reduce HIV...